Carlyle Group NASDAQ: CG has filed 13-F forms with the SEC as an investor. Carlyle Group is itself a publicly traded company. The Carlyle Group Inc. is an investment firm specializing in direct and fund of fund investments. Within direct investments, it specializes in management-led/ Leveraged buyouts, privatizations, divestitures, strategic minority equity investments, structured credit, global distressed and corporate opportunities, small and middle market, equity private placements, consolidations and buildups, senior debt, mezzanine and leveraged finance, and venture and growth capital financings, seed/startup, early venture, emerging growth, turnaround, mid venture, late venture, PIPES. For more information on Carlyle Group stock, visit the Carlyle Group stock profile here.
Investment Activity
- Carlyle Group has $10.62 billion in total holdings as of September 30, 2022.
- Carlyle Group owns shares of 20 different stocks, but just 2 companies or ETFs make up 80% of its holdings.
- Approximately 0.00% of the portfolio was purchased this quarter.
- About 28.39% of the portfolio was sold this quarter.
- This quarter, Carlyle Group has purchased 20 new stocks and bought additional shares in 0 stocks.
- Carlyle Group sold shares of 2 stocks and completely divested from 1 stock this quarter.
Largest Holdings
- Medline Inc
- $8,325,225,229
- Standardaero Inc
- $2,184,883,114
- Pony Ai Inc
- $22,301,500
Largest New Holdings this Quarter
- 42238D107 - Heartflow Inc
- $497,256 Holding
Largest Purchases this Quarter
- Heartflow Inc
- 20,438 shares (about $497.26K)
Largest Sales this Quarter
- Standardaero Inc
- 68,086,856 shares (about $1.76B)
- Medline Inc
- 28,219,323 shares (about $1.26B)
